FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:232 July 19, 2001 Number 3 Next

PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Keller, M. B.

A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression . On page 1464, the definition of response and remission that begins on line 18 in the left-hand column should have read, "Remission was defined a priori as an HRSD score of no more than 8 at both week 10 and week 12 for the analysis of those who completed the 12-week protocol, and at end point for the analysis of the modified intention-to-treat sample. A satisfactory therapeutic response was defined as a reduction in the HRSD score by at least 50 percent from base line to week 10 and week 12, with a total score of 15 or less at these times but of more than 8 at week 10, week 12, or both, for the analysis of those who completed the study, and at end point for the analysis of the modified intention-to-treat sample."

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.